uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted June 21, 2011

FDA Warns Laboratory of Manufacturing Violations

On June 10, 2011, the U.S. FDA posted a Warning Letter (dated 4/15/11) to Nutro Laboratories, a division of NBTY, Inc., concerning serious violations of the current Good Manufacturing Practice (CGMP) regulations for Dietary Supplements based on its inspection of Nutro facilities in October 2010. The violations observed at the Nutro facility primarily related to the ingredient crospovidone, an excipient used in supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at